Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05301036 · ClinicalTrials.gov registry record · Phase 1

Personalized Ultrasonic Brain Stimulation for Depression

A Phase 1 study of Major Depressive Episode, sponsored by University of Utah.

Active
Registry status
Phase 1
Development phase
20
Enrollment target
1
Study location

NCT05301036: Active Phase 1 study of Major Depressive Episode, sponsored by University of Utah.

NCT05301036 is a Phase 1 study of Major Depressive Episode that is active but no longer recruiting, run by University of Utah. The registered enrollment target is 20 participants, below the 209-participant average among 7 other Major Depressive Episode trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05301036, a Phase 1 study of Major Depressive Episode, is active but no longer recruiting, sponsored by University of Utah.

ACTIVE NOT RECRUITING
Registry status
Phase 1
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate a new form of non-invasive brain stimulation for individuals with depression. Personalized low-intensity transcranial focused ultrasound stimulation will first be delivered using a range of stimulation parameters during psychological and physiological monitoring. A well-tolerated stimulation protocol will then be selected for subsequent testing in a blinded randomized sham-controlled cross-over trial to evaluate brain target engagement using magnetic resonance imaging.

Conditions Studied

Interventions

  • DEVICE Diadem prototype

Study Locations (1)

Utah

  • University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2022-07-15
Est. Completion 2024-12-14
Phase Phase 1
University of Utah

818 total trials

What the registry record for NCT05301036 still lists

NCT05301036 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 209-participant average among 7 other Major Depressive Episode trials with a reported enrollment target (90% lower).

The record links to 1 condition, with Major Depressive Episode appearing as the primary indexed condition, and to 1 intervention - of which Diadem prototype is the first listed.

NCT05301036 reports a single indexed study location in Utah.

Frequently Asked Questions

What is clinical trial NCT05301036 about?

NCT05301036 is a clinical study titled "Personalized Ultrasonic Brain Stimulation for Depression". This study will evaluate a new form of non-invasive brain stimulation for individuals with depression. Personalized low-intensity transcranial focused ultrasound stimulation will first be delivered using a range of stimulation parameters during psychological and physiological monitoring. A well-tole...

What is the current status of trial NCT05301036?

This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2022-07-15. Estimated completion is 2024-12-14.

What conditions does trial NCT05301036 study?

This clinical trial studies the following conditions: Major Depressive Episode.

What interventions are being tested in trial NCT05301036?

The interventions under investigation include: Diadem prototype (DEVICE).

Who is sponsoring clinical trial NCT05301036?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05301036 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Major Depressive Episode

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05301036, the US trial registry maintained by the National Library of Medicine. NCT05301036 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.